LONHALA MAGNAIR KIT (glycopyrrolate) Sunovion resp Patent: 7,316,067 Expiration: Sep 6, 2022 See More … For more information on how […]
Drug Patent Expirations for the Week of September 4, 2022 Read Post »
Annual Drug Patent Expirations for AMITIZA Amitiza is a drug marketed by Sucampo Pharma Llc and is included in one
New patent expiration for Sucampo Pharma drug AMITIZA Read Post »
Annual Drug Patent Expirations for LEVAQUIN Levaquin is a drug marketed by Janssen Pharms and is included in three NDAs.
New patent expiration for Janssen Pharms drug LEVAQUIN Read Post »
LEVAQUIN (levofloxacin) Janssen pharms Patent: 6,806,256 Expiration: Aug 26, 2022 See More … For more information on how DrugPatentWatch can
Drug Patent Expirations for the Week of August 21, 2022 Read Post »
Annual Drug Patent Expirations for VIBATIV Vibativ is a drug marketed by Cumberland Pharms and is included in one NDA.
New patent expiration for Cumberland Pharms drug VIBATIV Read Post »
Annual Drug Patent Expirations for AFINITOR Afinitor is a drug marketed by Novartis and Novartis Pharm and is included in
New patent expiration for Novartis drug AFINITOR Read Post »
Annual Drug Patent Expirations for AFINITOR+DISPERZ Afinitor Disperz is a drug marketed by Novartis Pharm and is included in one
New patent expiration for Novartis Pharm drug AFINITOR DISPERZ Read Post »
Annual Drug Patent Expirations for AFINITOR Afinitor is a drug marketed by Novartis and Novartis Pharm and is included in
New patent expiration for Novartis drug AFINITOR Read Post »
AFINITOR (everolimus) Novartis Patent: 8,778,962 Expiration: Aug 18, 2022 See More … For more information on how DrugPatentWatch can help
Drug Patent Expirations for the Week of August 14, 2022 Read Post »
Get fresh news and insights, drug patent expirations & more…
